← Open Payments lookup

JENNIFER CECIL: Open Payments

NPI 1437450822 · MAGNA, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$453 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $453

Food & beverage: $453
CompanyPaymentsAmount
Edwards Lifesciences Corporation1$202
GlaxoSmithKline, LLC.1$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$90
Astellas Pharma US Inc1$19
Xeris Pharmaceuticals, Inc.1$19
Smith+Nephew, Inc.1$17
AstraZeneca Pharmaceuticals LP1$14

Products named: SAPIEN 3 Ultra RESILIA, AREXVY, CAPLYTA, Veozah, GVOKE HYPOPEN, STRAVIX, BREZTRI.

Industry payments across UT — which companies pay providers there.